Effect of Talar Mobilization With Movement Versus Acupuncture on Knee Pain and Function in the Postmenopausal Women
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06051903 |
Recruitment Status :
Not yet recruiting
First Posted : September 25, 2023
Last Update Posted : February 28, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Talar Mobilization Acupuncture | Other: Mobilization wih movement | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Effect of Talar Mobilization With Movement Versus Acupuncture on Knee Pain and Function in the Postmenopausal Women |
Estimated Study Start Date : | March 2024 |
Estimated Primary Completion Date : | May 2024 |
Estimated Study Completion Date : | June 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Talar mobilization with movement
(group A) postmenopausal women who receive the talar mobilization with movement technique for knee joint , their age raged from 50-60 years (n= 20)
|
Other: Mobilization wih movement
The purpose of this study is to determine the effect of talar mobilization with movement versus acupuncture on knee pain and function in the postmenopausal women |
Experimental: Acupuncture for knee joint
(group B) postmenopausal women who receive acupuncture for knee joint (n= 20), their age ranged from 50-60 years
|
Other: Mobilization wih movement
The purpose of this study is to determine the effect of talar mobilization with movement versus acupuncture on knee pain and function in the postmenopausal women |
- . Numeric pain rating scale [ Time Frame: up to 4 weeks ]it will measure pain intensity
- KOOS questionnaire [ Time Frame: up to 4 weeks ]To measure success of range of motion
- Pressure algometer [ Time Frame: up to 4 weeks ]To measure the pain
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 60 Years (Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | their age ranged from 50-60 years |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- ) Females patients refered from orthopedic surgeon diagnosed with knee OA (2) Their age ranged from 50 _60 years old 3) Their BMI less than 30 kg/m2. 5) knee pain in the previous week with an intensity of at least 3 points on a numeric pain rating scale (NPRS ) (5) Patients limited ankle dorsiflexion ROM 6) All Patients had 3 points on NPS (7) Presence of knee pain for at least 3 moonths 8) All patients were given the arabic version of KOOS questionnaire
Exclusion Criteria:
- 1) Patients with Rheumatoid arthritis 2) Their BMI more than 30 kg/m2. 3) Unrelated to any traumatic knee event 4) Patients with Previous tibial fracture 5) Patients with Ankle instability 6) Patients with previous meniscal degeneration 7) Patients with hyper laxity 8) Patients with neurological disorders
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06051903
Contact: Kerolous Kelini | +201229712126 | Kerolous.ishak.pt@o6u.edu.eg |
Responsible Party: | Kerolous Ishak Shehata, principle investigator, October 6 University |
ClinicalTrials.gov Identifier: | NCT06051903 |
Other Study ID Numbers: |
p.t.REC\012\004591 |
First Posted: | September 25, 2023 Key Record Dates |
Last Update Posted: | February 28, 2024 |
Last Verified: | February 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |